These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
568 related articles for article (PubMed ID: 20522787)
1. Extracellular ATP is a danger signal activating P2X7 receptor in lung inflammation and fibrosis. Riteau N; Gasse P; Fauconnier L; Gombault A; Couegnat M; Fick L; Kanellopoulos J; Quesniaux VF; Marchand-Adam S; Crestani B; Ryffel B; Couillin I Am J Respir Crit Care Med; 2010 Sep; 182(6):774-83. PubMed ID: 20522787 [TBL] [Abstract][Full Text] [Related]
2. Uric acid is a danger signal activating NALP3 inflammasome in lung injury inflammation and fibrosis. Gasse P; Riteau N; Charron S; Girre S; Fick L; Pétrilli V; Tschopp J; Lagente V; Quesniaux VF; Ryffel B; Couillin I Am J Respir Crit Care Med; 2009 May; 179(10):903-13. PubMed ID: 19218193 [TBL] [Abstract][Full Text] [Related]
3. Asiatic acid ameliorates pulmonary fibrosis induced by bleomycin (BLM) via suppressing pro-fibrotic and inflammatory signaling pathways. Dong SH; Liu YW; Wei F; Tan HZ; Han ZD Biomed Pharmacother; 2017 May; 89():1297-1309. PubMed ID: 28320097 [TBL] [Abstract][Full Text] [Related]
4. [Regulatory effect of hemichannels protein Pannexin-1 on P2X7 receptor activity in the lungs of mice with lung injury]. Li N; Jia J; Wu X; Zhao Y; Zang B Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2018 Nov; 30(11):1071-1076. PubMed ID: 30541648 [TBL] [Abstract][Full Text] [Related]
5. Involvement of purinergic receptors and NOD-like receptor-family protein 3-inflammasome pathway in the adenosine triphosphate-induced cytokine release from macrophages. Gicquel T; Victoni T; Fautrel A; Robert S; Gleonnec F; Guezingar M; Couillin I; Catros V; Boichot E; Lagente V Clin Exp Pharmacol Physiol; 2014 Apr; 41(4):279-86. PubMed ID: 24472059 [TBL] [Abstract][Full Text] [Related]
6. Extracellular release of ATP promotes systemic inflammation during acute pancreatitis. Dixit A; Cheema H; George J; Iyer S; Dudeja V; Dawra R; Saluja AK Am J Physiol Gastrointest Liver Physiol; 2019 Oct; 317(4):G463-G475. PubMed ID: 31433214 [TBL] [Abstract][Full Text] [Related]
8. Elevation of IL-6 and IL-33 Levels in Serum Associated with Lung Fibrosis and Skeletal Muscle Wasting in a Bleomycin-Induced Lung Injury Mouse Model. Shieh JM; Tseng HY; Jung F; Yang SH; Lin JC Mediators Inflamm; 2019; 2019():7947596. PubMed ID: 31049028 [TBL] [Abstract][Full Text] [Related]
9. Essential role of stem cell factor-c-Kit signalling pathway in bleomycin-induced pulmonary fibrosis. Ding L; Dolgachev V; Wu Z; Liu T; Nakashima T; Wu Z; Ullenbruch M; Lukacs NW; Chen Z; Phan SH J Pathol; 2013 Jun; 230(2):205-14. PubMed ID: 23401096 [TBL] [Abstract][Full Text] [Related]
10. The XPO1 inhibitor selinexor ameliorates bleomycin-induced pulmonary fibrosis in mice via GBP5/NLRP3 inflammasome signaling. Zhang J; Zhang Y; Chen Q; Qi Y; Zhang X Int Immunopharmacol; 2024 Mar; 130():111734. PubMed ID: 38422768 [TBL] [Abstract][Full Text] [Related]
11. Highly Selective Endothelin-1 Receptor A Inhibition Prevents Bleomycin-Induced Pulmonary Inflammation and Fibrosis in Mice. Manitsopoulos N; Nikitopoulou I; Maniatis NA; Magkou C; Kotanidou A; Orfanos SE Respiration; 2018; 95(2):122-136. PubMed ID: 29131071 [TBL] [Abstract][Full Text] [Related]
12. IL-1 and IL-23 mediate early IL-17A production in pulmonary inflammation leading to late fibrosis. Gasse P; Riteau N; Vacher R; Michel ML; Fautrel A; di Padova F; Fick L; Charron S; Lagente V; Eberl G; Le Bert M; Quesniaux VF; Huaux F; Leite-de-Moraes M; Ryffel B; Couillin I PLoS One; 2011; 6(8):e23185. PubMed ID: 21858022 [TBL] [Abstract][Full Text] [Related]
13. Pirfenidone ameliorates lipopolysaccharide-induced pulmonary inflammation and fibrosis by blocking NLRP3 inflammasome activation. Li Y; Li H; Liu S; Pan P; Su X; Tan H; Wu D; Zhang L; Song C; Dai M; Li Q; Mao Z; Long Y; Hu Y; Hu C Mol Immunol; 2018 Jul; 99():134-144. PubMed ID: 29783158 [TBL] [Abstract][Full Text] [Related]
14. Fluorofenidone attenuates pulmonary inflammation and fibrosis via inhibiting the activation of NALP3 inflammasome and IL-1β/IL-1R1/MyD88/NF-κB pathway. Song C; He L; Zhang J; Ma H; Yuan X; Hu G; Tao L; Zhang J; Meng J J Cell Mol Med; 2016 Nov; 20(11):2064-2077. PubMed ID: 27306439 [TBL] [Abstract][Full Text] [Related]
15. Characterization of lung stem cell niches in a mouse model of bleomycin-induced fibrosis. Banerjee ER; Henderson WR Stem Cell Res Ther; 2012 May; 3(3):21. PubMed ID: 22643035 [TBL] [Abstract][Full Text] [Related]
16. B cell activating factor is central to bleomycin- and IL-17-mediated experimental pulmonary fibrosis. François A; Gombault A; Villeret B; Alsaleh G; Fanny M; Gasse P; Adam SM; Crestani B; Sibilia J; Schneider P; Bahram S; Quesniaux V; Ryffel B; Wachsmann D; Gottenberg JE; Couillin I J Autoimmun; 2015 Jan; 56():1-11. PubMed ID: 25441030 [TBL] [Abstract][Full Text] [Related]